| 0 (0%) | 05-01 03:13 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 8.86 | 1-year : | 10.35 |
| Resists | First : | 7.59 | Second : | 8.86 |
| Pivot price | 7.37 |
|||
| Supports | First : | 7.34 | Second : | 7.19 |
| MAs | MA(5) : | 7.49 |
MA(20) : | 7.39 |
| MA(100) : | 7.44 |
MA(250) : | 7.39 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1  |
| %K %D | K(14,3) : | 68.3 |
D(3) : | 77.1 |
| RSI | RSI(14): 48.4 |
|||
| 52-week | High : | 8.14 | Low : | 6.09 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ PMX ] has closed below upper band by 42.3%. Bollinger Bands are 20.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 7.51 - 7.56 | 7.56 - 7.59 |
| Low: | 7.28 - 7.34 | 7.34 - 7.38 |
| Close: | 7.33 - 7.42 | 7.42 - 7.48 |
Thu, 22 Jul 2021
American Locos in the Tropics: Yucatán Short Line - Railfan & Railroad Magazine
Mon, 18 May 2020
BioPharmX Announces 1-for-12 Reverse Stock Split Merger Transaction Expected to Close on May 18, 2020 - PR Newswire
Wed, 13 May 2020
BioPharmX Corporation Announces Approval of Merger by Stockholders at Special Meeting - PR Newswire
Tue, 28 Jan 2020
BioPharmX And Timber Pharmaceuticals Announce Entry into Merger Agreement - PR Newswire
Mon, 20 Jul 2015
BioPharmX Launches #HugsShouldntHurt Social Media Campaign - BioSpace
Tue, 09 Dec 2014
INTRODUCING VIOLET™ IODINE, NEW ONCE-DAILY, NON-PRESCRIPTION PILL FOR RELIEF OF ... - MultiVu
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 33 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0.1 (%) |
| Held by Institutions | 20.7 (%) |
| Shares Short | 74 (K) |
| Shares Short P.Month | 32 (K) |
| EPS | 0.63 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.31 |
| Profit Margin | 135.6 % |
| Operating Margin | 83.9 % |
| Return on Assets (ttm) | 2.4 % |
| Return on Equity (ttm) | 7.2 % |
| Qtrly Rev. Growth | -6.6 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0.66 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 45 (M) |
| Levered Free Cash Flow | 16 (M) |
| PE Ratio | 11.57 |
| PEG Ratio | 0 |
| Price to Book value | 0.89 |
| Price to Sales | 11.14 |
| Price to Cash Flow | 5.5 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|